- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00091429
Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine
November 24, 2009 updated by: Gilead Sciences
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of Ranolazine SR at a Dose of 1000 mg Twice a Day in Patients With Chronic Angina Who Remain Symptomatic Despite Treatment With Amlodipine 10 mg Once a Day
The study will be a multi-national, double-blind, randomized, placebo-controlled, parallel group study to evaluate the effectiveness of ranolazine (1000 mg twice daily) in approximately 500 patients with chronic angina who remain symptomatic despite daily treatment with the maximum labeled dose of amlodipine (10 mg daily), a calcium channel blocker approved for the treatment of chronic angina.
Eligible patients will be randomized to receive ranolazine 1000 mg or placebo twice daily, in addition to a daily dose of 10 mg of amlodipine.
Participation in the study will last approximately 3 months.
Study Overview
Study Type
Interventional
Enrollment
500
Phase
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Eligible patients must have a diagnosis of chronic angina, with documented evidence of coronary artery disease or prior myocardial infarction, in addition to other study entry criteria.
Prior to entering the study, patients will be required to have had at least two weeks of treatment with amlodipine 10 mg daily, with the discontinuation of all other anti-anginal therapy for the duration of the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L; ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol. 2006 Aug 1;48(3):566-75. doi: 10.1016/j.jacc.2006.05.044. Epub 2006 Jun 15.
- Kohn CG, Parker MW, Limone BL, Coleman CI. Impact of angina frequency on health utility values of patients with chronic stable angina. Health Qual Life Outcomes. 2014 Mar 14;12:39. doi: 10.1186/1477-7525-12-39.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2004
Primary Completion (Actual)
February 1, 2005
Study Completion (Actual)
February 1, 2005
Study Registration Dates
First Submitted
September 8, 2004
First Submitted That Met QC Criteria
September 9, 2004
First Posted (Estimate)
September 10, 2004
Study Record Updates
Last Update Posted (Estimate)
November 26, 2009
Last Update Submitted That Met QC Criteria
November 24, 2009
Last Verified
November 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CVT 3037
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Angina
-
Korea University Anam HospitalCompletedDiabetic Stable Angina | Diabetic Unstable AnginaKorea, Republic of
-
Roxane LaboratoriesCompletedHypertension | Vasospastic Angina | Chronic Stable AnginaUnited States
-
Bon-Kwon KooSamsung Medical Center; Chonnam National University Hospital; Seoul National... and other collaboratorsCompleted
-
Ulsan University HospitalSeoul National University HospitalCompletedStable Angina | Unstable AnginaKorea, Republic of
-
Medhub Ltd.CompletedStable Angina | Unstable Angina | NSTEMIIsrael
-
Ospedale San DonatoTerminatedStable Angina | Unstable AnginaItaly
-
CID - Carbostent & Implantable DevicesCompletedStable Angina | Unstable Angina | NSTEMINetherlands, Italy
-
Roxane LaboratoriesCompletedHypertension | Vasospastic Angina | Chronic Stable AnginaUnited States
-
IHF GmbH - Institut für HerzinfarktforschungOrbusNeichWithdrawnCoronary Disease | Stable Angina | Unstable Angina | STEMI | NSTEMIGermany
-
CID - Carbostent & Implantable DevicesCompletedStable Angina | Unstable Angina | Documented Silent IschemiaFrance, Germany, Belgium, Italy
Clinical Trials on Ranolazine
-
University of Kansas Medical CenterGilead SciencesUnknown
-
University of California, San DiegoTerminatedDiastolic Heart Failure | Echocardiography | Ranolazine | Tissue Doppler UltrasoundUnited States
-
University CardiologyUnknownIschemic Mitral RegurgitationUnited States
-
Kent Hospital, Rhode IslandGilead SciencesCompletedMyocardial Ischemia | Ventricular Premature ComplexesUnited States
-
Cardiovascular Consultants of NevadaGilead SciencesUnknownCoronary Artery Disease | Atrial Fibrillation | Ventricular Tachycardia | Chronic Stable AnginaUnited States
-
Gilead SciencesCompletedMyocardial Ischemia | Myocardial Perfusion ImagingUnited States, Finland, Israel, Canada, Italy, Singapore, Czech Republic, United Kingdom
-
Novartis PharmaceuticalsTerminatedAtherosclerotic Coronary Vascular DiseaseUnited States
-
Gilead SciencesCompletedCoronary Artery Disease | Type 2 Diabetes Mellitus | Angina PectorisCanada, Slovenia, United States, Israel, Germany, Georgia, Russian Federation, Czech Republic, Belarus, Bulgaria, Poland, Serbia, Slovakia, Ukraine
-
Gilead SciencesCompletedAtrial FibrillationUnited States, Italy, Poland, Germany, Israel, Netherlands, United Kingdom
-
IRCCS San RaffaeleMenarini International Operations Luxembourg SACompletedHCM - Hypertrophic Non-Obstructive CardiomyopathyItaly